Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest Content
Archive
For authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest Content
Archive
For authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Rheumatoid Arthritis
Email alerts
Rheumatoid Arthritis
Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?
Sofia
Ramiro
,
Robert
Landewé
,
Désirée
van der Heijde
,
David
Harrison
,
David
Collier
,
Kaleb
Michaud
RMD Open
Nov 2015,
1
(1)
e000155;
DOI:
10.1136/rmdopen-2015-000155
Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry
Sofie H M
Manders
,
Mart A F J
van de Laar
,
Sanne A A
Rongen-van Dartel
,
Reinhard
Bos
,
Henk
Visser
,
Herman L
Brus
,
Tim
Jansen
,
Harald E
Vonkeman
,
Piet L C M
van Riel
,
Wietske
Kievit
RMD Open
Oct 2015,
1
(1)
e000147;
DOI:
10.1136/rmdopen-2015-000147
Structural integrity versus radiographic progression in rheumatoid arthritis
Ennio Giulio
Favalli
,
Andrea
Becciolini
,
Martina
Biggioggero
RMD Open
Aug 2015,
1
(Suppl 1)
e000064;
DOI:
10.1136/rmdopen-2015-000064
OsteoRheumatology: a new discipline?
Marta
Favero
,
Andrea
Giusti
,
Piet
Geusens
,
Steven R
Goldring
,
Willem
Lems
,
Georg
Schett
,
Gerolamo
Bianchi
RMD Open
Aug 2015,
1
(Suppl 1)
e000083;
DOI:
10.1136/rmdopen-2015-000083
Bone and TNF in rheumatoid arthritis: clinical implications
Maria
Manara
,
Luigi
Sinigaglia
RMD Open
Aug 2015,
1
(Suppl 1)
e000065;
DOI:
10.1136/rmdopen-2015-000065
Rheumatoid arthritis treatment: the earlier the better to prevent joint damage
Sara
Monti
,
Carlomaurizio
Montecucco
,
Serena
Bugatti
,
Roberto
Caporali
RMD Open
Aug 2015,
1
(Suppl 1)
e000057;
DOI:
10.1136/rmdopen-2015-000057
Glucocorticoids: bad or safe for the bones?
Willem F
Lems
RMD Open
Aug 2015,
1
(Suppl 1)
e000050;
DOI:
10.1136/rmdopen-2015-000050
Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis
Rieke
Alten
,
Amy
Grahn
,
Robert J
Holt
,
Patricia
Rice
,
Frank
Buttgereit
RMD Open
Aug 2015,
1
(1)
e000134;
DOI:
10.1136/rmdopen-2015-000134
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study
Michael
Schiff
,
Bernard
Combe
,
Thomas
Dörner
,
Joel M
Kremer
,
Thomas W
Huizinga
,
Melissa
Veenhuizen
,
Anne
Gill
,
Wendy
Komocsar
,
Pierre-Yves
Berclaz
,
Robert
Ortmann
,
Chin
Lee
RMD Open
Aug 2015,
1
(1)
e000037;
DOI:
10.1136/rmdopen-2014-000037
Biologicals in rheumatoid arthritis: current and future
Ali Berkant
Avci
,
Eugen
Feist
,
Gerd-R
Burmester
RMD Open
Aug 2015,
1
(1)
e000127;
DOI:
10.1136/rmdopen-2015-000127
Pages
« first
‹ previous
…
19
20
21
22
23
24
25
26
27
next ›
last »
Special collections
Guidelines, Recommendations and Consensus Statements
Press releases
(1)
